Back to ROSG Stock Lookup

Rosetta Genomics (ROSG) – Press Releases

May 28, 2015 09:06 AM Rosetta Genomics Launches OncoGxOne™
May 26, 2015 09:00 AM Rosetta Genomics Announces Selection of First Pilot Project Grant under Strategic Alliance with Moffitt Cancer Center
May 14, 2015 08:48 AM Rosetta Genomics Launches Two Assays for Bladder Cancer
May 13, 2015 09:07 AM Rosetta Genomics Receives Additional U.S. Patent Protection for the Cancer Origin Test™
May 12, 2015 08:23 AM Data on Rosetta Genomics’ Novel Thyroid Nodule Classification Assay to be Presented at the American Association of Clinical Endocrinologists 24th Annual Scientific and Clinical Congress
Apr 29, 2015 08:56 AM Rosetta Genomics’ Patent on Therapeutic Use of miR-34a Upheld by European Patent Office in Opposition Proceedings
Apr 20, 2015 08:30 AM Rosetta Genomics Announces Data Published in Leukemia Research
Apr 16, 2015 09:15 AM Rosetta Genomics Receives Key U.S. Patent Allowance for its Cancer of Origin Diagnostic Assay
Apr 14, 2015 08:30 AM Rosetta Genomics Completes Acquisition of PersonalizeDx
Apr 9, 2015 12:16 PM Rosetta Genomics to Acquire PersonalizeDx
Mar 26, 2015 08:30 AM Rosetta Genomics Receives Key U.S. Patent Allowance for its Novel Kidney Cancer Test
Mar 25, 2015 08:00 AM Rosetta Genomics to Launch Next-Generation Sequencing Panel from Admera Health
Mar 16, 2015 04:30 PM Rosetta Genomics Reports 2014 Financial Results
Mar 10, 2015 12:31 PM Rosetta Genomics to Host Business Update and 2014 Year End Financials Conference Call on March 17, 2015
Mar 4, 2015 08:31 AM Rosetta Genomics to Present at the 27th Annual ROTH Conference

Back to ROSG Stock Lookup